4//SEC Filing
Lawlor Sally Bridget 4
Accession 0001104659-25-118190
CIK 0001671502other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:39 PM ET
Size
6.4 KB
Accession
0001104659-25-118190
Insider Transaction Report
Form 4
Lawlor Sally Bridget
CHIEF FINANCIAL OFFICER
Transactions
- Award
Share Option (Right to Buy)
2025-12-01+10,330→ 10,330 totalExercise: $19.36Exp: 2035-12-01→ ADS (10,330 underlying)
Footnotes (3)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.
- [F2]The option grant was approved by the Compensation Committee of the Board of Directors of the Issuer on December 1, 2025.
- [F3]The option vests in four annual installments with 20% vesting on each of December 1, 2026, 2027 and 2028 and 40% vesting on December 1, 2029.
Documents
Issuer
Quoin Pharmaceuticals, Ltd.
CIK 0001671502
Entity typeother
Related Parties
1- filerCIK 0002084407
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:39 PM ET
- Size
- 6.4 KB